Insights

Major Acquisition Merck acquired Acceleron Pharma for $11.5 billion, emphasizing a significant investment in biotechnology research and expanding their portfolio with a focus on pulmonary arterial hypertension drugs.

Blockbuster Drug Potential With the successful launch of Reblozyl and plans to expand into treating myelodysplastic syndromes (MDS), Acceleron Pharma is poised to introduce blockbuster therapies that can drive substantial revenue growth.

Strategic Partnerships Acceleron Pharma entered into a merger agreement with Merck and partnered with them, indicating a focus on collaboration to leverage each other's strengths and access new markets efficiently.

Legal Challenges The ongoing investigation surrounding fiduciary duty breaches highlights a potential area where Acceleron Pharma may need legal support, presenting an opportunity for legal services or support in resolving corporate conflicts.

High-value Asset Sale The sale of assets worth $11.5 billion to Merck showcases a strong financial transaction, indicating the potential for financial services or solutions related to high-value acquisitions and equity deals.

Acceleron Pharma Tech Stack

Acceleron Pharma uses 8 technology products and services including Google Analytics, GitHub, SAP, and more. Explore Acceleron Pharma's tech stack below.

  • Google Analytics
    Analytics
  • GitHub
    Communication And Collaboration
  • SAP
    Customer Relationship Management
  • Microsoft Excel
    Editors
  • Modernizr
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • reCAPTCHA
    Security
  • Linkedin
    Widgets

Media & News

Acceleron Pharma's Email Address Formats

Acceleron Pharma uses at least 1 format(s):
Acceleron Pharma Email FormatsExamplePercentage
FLast@acceleronpharma.comJDoe@acceleronpharma.com
92%
First.Last@acceleronpharma.comJohn.Doe@acceleronpharma.com
5%
Last@acceleronpharma.comDoe@acceleronpharma.com
2%
First@acceleronpharma.comJohn@acceleronpharma.com
1%

Frequently Asked Questions

Where is Acceleron Pharma's headquarters located?

Minus sign iconPlus sign icon
Acceleron Pharma's main headquarters is located at 128 Sidney Street Cambridge, MA 02139 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Acceleron Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Acceleron Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Acceleron Pharma's stock symbol?

Minus sign iconPlus sign icon
Acceleron Pharma is a publicly traded company; the company's stock symbol is XLRN.

What is Acceleron Pharma's official website and social media links?

Minus sign iconPlus sign icon
Acceleron Pharma's official website is acceleronpharma.com and has social profiles on LinkedIn.

How much revenue does Acceleron Pharma generate?

Minus sign iconPlus sign icon
As of December 2024, Acceleron Pharma's annual revenue reached $75M.

What is Acceleron Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Acceleron Pharma's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 424210 - Drugs and Druggists' Sundries Merchant Wholesalers.

How many employees does Acceleron Pharma have currently?

Minus sign iconPlus sign icon
As of December 2024, Acceleron Pharma has approximately 201 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: J. K.Chief Operating Officer: S. E.Vice President Of Information Technology And Facilities: M. M.. Explore Acceleron Pharma's employee directory with LeadIQ.

What industry does Acceleron Pharma belong to?

Minus sign iconPlus sign icon
Acceleron Pharma operates in the Biotechnology Research industry.

What technology does Acceleron Pharma use?

Minus sign iconPlus sign icon
Acceleron Pharma's tech stack includes Google AnalyticsGitHubSAPMicrosoft ExcelModernizrHubSpotreCAPTCHALinkedin.

What is Acceleron Pharma's email format?

Minus sign iconPlus sign icon
Acceleron Pharma's email format typically follows the pattern of . Find more Acceleron Pharma email formats with LeadIQ.

How much funding has Acceleron Pharma raised to date?

Minus sign iconPlus sign icon
As of December 2024, Acceleron Pharma has raised $493M in funding. The last funding round occurred on Jun 30, 2020 for $493M.

When was Acceleron Pharma founded?

Minus sign iconPlus sign icon
Acceleron Pharma was founded in 2003.
Acceleron Pharma

Acceleron Pharma

Biotechnology ResearchMassachusetts, United States201-500 Employees

Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com

Section iconCompany Overview

Headquarters
128 Sidney Street Cambridge, MA 02139 US
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
XLRN
NAICS Code
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
Founded
2003
Employees
201-500

Section iconFunding & Financials

  • $493M

    Acceleron Pharma has raised a total of $493M of funding over 15 rounds. Their latest funding round was raised on Jun 30, 2020 in the amount of $493M.

  • $50M$100M

    Acceleron Pharma's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $493M

    Acceleron Pharma has raised a total of $493M of funding over 15 rounds. Their latest funding round was raised on Jun 30, 2020 in the amount of $493M.

  • $50M$100M

    Acceleron Pharma's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.